Clinical Trial Update: Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of cabozantinib with ifosfamide in relapsed/refractory sarcomas is currently recruiting at Children's Hospital of Phi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Osteosarcoma

Drugs mentioned

• IFOSFAMIDE (IFOSFAMIDE)
• cabozantinib (cabozantinib)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Ewing Sarcoma, Osteosarcoma | Phase 1 | Status: RECRUITING